vs

Side-by-side financial comparison of Evogene Ltd. (EVGN) and ICL Group Ltd. (ICL). Click either name above to swap in a different company.

Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technolo...

ICL Group Ltd. is a multi-national manufacturing concern that develops, produces and markets fertilizers, metals and other special-purpose chemical products. ICL serves primarily three markets: agriculture, food and engineered materials. ICL produces approximately a third of the world's bromine, and is the world's sixth-largest potash producer. It is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EVGN
EVGN
ICL
ICL
Q2 25
$3.2M
Q2 24
$2.3M
Net Profit
EVGN
EVGN
ICL
ICL
Q2 25
$-7.7M
Q2 24
$-9.8M
Gross Margin
EVGN
EVGN
ICL
ICL
Q2 25
48.8%
Q2 24
71.8%
Operating Margin
EVGN
EVGN
ICL
ICL
Q2 25
-189.0%
Q2 24
-409.9%
Net Margin
EVGN
EVGN
ICL
ICL
Q2 25
-237.7%
Q2 24
-428.5%
EPS (diluted)
EVGN
EVGN
ICL
ICL
Q2 25
Q2 24
$-1.82

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons